KUALA LUMPUR: Duopharma Biotech Bhd
’s expansion into the Indonesian market will enable the group to create a bigger global presence and seize exciting opportunities for collaboration that will in turn contribute to better healthcare outcomes.
In the first quarter ended March 31, the pharmaceutical group posted a net profit of RM22.6mil, up 11.5% from RM20.3mil posted a year ago.
Its revenue rose 7.8% to RM200.5mil compared with RM185.9mil in the corresponding period last year.
Earnings per share for the quarter amounted to 2.38 sen, compared with 2.19 sen previously.
